We are Looking for Partners to Build This With
Out-licensing, co-development and technology transfer can all be discussed from cell line development onward. Territory-exclusive licences and co-development collaborations are always open.
Partnership Models
Four Ways to Work Together
Licensing
Territory-exclusive licences, benchmarked to efficacy POC, with terms negotiated in confidence.
Co-Development
A joint pipeline entered from cell line development onward. It covers shared CMC, regional development, and supply and field-trial agreements.
Manufacturing
Partners lead late-stage development and commercial supply. GMP manufacture, tech transfer and field trials run with established CDMOs and CROs.
Platform Access
CHO-Speed™ cell line development offered as a service to third parties.
Who We are Looking For
- Global animal health companies
- Animal health divisions of pharmaceutical companies holding human GLP-1 assets
- Global mid-to-large biologics CDMOs and CROs
- Leading commercialisation partners in any region — we do not limit territory
Available Assets
STAR-K9E · STAR-M3W
Seeking co-development partners and territory-exclusive licensees at efficacy POC.
STAR-CTRV02 · STAR-CAD · STAR-K9E2
HER2-positive mammary tumour, atopic dermatitis and the GLP-1/GIP dual agonist, all available for early out-licensing.
Every Region
We talk to partners anywhere in the world, and territory-exclusive licences are available.
Partnering & Investment Enquiries
We welcome licensing, partnering and investment enquiries. Commercial terms, technical data and investment materials are provided under an executed CDA.